Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines

SIMPLE SUMMARY: The development of nucleic acid drugs has progressed in recent years, especially in the field of cancer therapy, where there has been considerable progress in the development of siRNA-, antisense oligonucleotide-, and miRNA-related drugs. Extracellular vesicles are expected to play a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuriyama, Naoya, Yoshioka, Yusuke, Kikuchi, Shinsuke, Okamura, Akihiko, Azuma, Nobuyoshi, Ochiya, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656933/
https://www.ncbi.nlm.nih.gov/pubmed/34885247
http://dx.doi.org/10.3390/cancers13236137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656933/
https://www.ncbi.nlm.nih.gov/pubmed/34885247
http://dx.doi.org/10.3390/cancers13236137

Ejemplares similares